Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-93.60	-4.38	68.50
Graham Fair Price	40.11	0.01	< 0.005
PEG	-89.19	-0.01	0.11
Price/Book	-32.71	8.04	11.94
Price/Cash Flow	76.96	-2.21	-9.61
Prices/Earnings	66.35	-1.20	-3.55
Price/Sales	16.08	45.90	39.55
Price/FCF	76.96	-2.21	-9.61
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-1274.49	-3.96	-0.29
Operating Margin	-325.93	-15.03	-3.53
ROA	-100.00	-0.20	-0.10
ROE	-0.84	-1.68	-100.00
ROIC	-0.16	-0.27	-65.92
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	-0.10	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.39	-1.47	272.42
EPS QOQ	0.32	-1.00	211.11
FCF QOQ	0.29	-1.92	559.89
Revenue QOQ	20.13	-0.42	-97.91
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	28.47	12.75	-55.20
Days Sales Outstanding (DSO)	17.32	501.68	2796.80
Inventory Turnover	3.16	7.06	123.21
Debt/Capitalization	0.87	0.87	0.00
Quick Ratio	3.86	4.92	27.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	< 0.005	< 0.005	-0.93
Cash	< 0.005	< 0.005	-0.93
Capex	0.00	< 0.005	-100.00
Free Cash Flow	< 0.005	< 0.005	-189.32
Revenue	< 0.005	< 0.005	-42.57
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	5.08	5.08	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.50	-1.33	-91.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating